508 related items for PubMed ID: 27070994
1. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin.
Kibata T, Suzuki Y, Hasegawa S, Matsushige T, Kusuda T, Hoshide M, Takahashi K, Okada S, Wakiguchi H, Moriwake T, Uchida M, Ohbuchi N, Iwai T, Hasegawa M, Ichihara K, Yashiro M, Makino N, Nakamura Y, Ohga S.
Int J Cardiol; 2016 Jul 01; 214():209-15. PubMed ID: 27070994
[Abstract] [Full Text] [Related]
2. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 01; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
3. Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012.
Chen JJ, Ma XJ, Liu F, Yan WL, Huang MR, Huang M, Huang GY, Shanghai Kawasaki Disease Research Group.
Pediatr Infect Dis J; 2016 Jan 01; 35(1):7-12. PubMed ID: 26372452
[Abstract] [Full Text] [Related]
4. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.
Xie LP, Yan WL, Huang M, Huang MR, Chen S, Huang GY, Liu F.
J Epidemiol; 2020 Oct 05; 30(10):429-435. PubMed ID: 31548437
[Abstract] [Full Text] [Related]
5. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May 05; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
6. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 May 05; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
7. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
Wei M, Huang M, Chen S, Huang G, Huang M, Qiu D, Guo Z, Jiang J, Zhou X, Yu Q, Guo Y, Fu L, Gao W, Li F.
Pediatr Cardiol; 2015 Aug 05; 36(6):1166-72. PubMed ID: 25812827
[Abstract] [Full Text] [Related]
8. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
Pediatr Neonatol; 2014 Oct 05; 55(5):387-92. PubMed ID: 24636168
[Abstract] [Full Text] [Related]
9. Kawasaki disease in Sicily: clinical description and markers of disease severity.
Maggio MC, Corsello G, Prinzi E, Cimaz R.
Ital J Pediatr; 2016 Nov 02; 42(1):92. PubMed ID: 27806720
[Abstract] [Full Text] [Related]
10. Serum Tenascin-C as a Novel Predictor for Risk of Coronary Artery Lesion and Resistance to Intravenous Immunoglobulin in Kawasaki Disease - A Multicenter Retrospective Study.
Okuma Y, Suda K, Nakaoka H, Katsube Y, Mitani Y, Yoshikane Y, Ichida F, Matsushita T, Shichino H, Shiraishi I, Abe J, Hiroe M, Yoshida T, Imanaka-Yoshida K.
Circ J; 2016 Oct 25; 80(11):2376-2381. PubMed ID: 27746411
[Abstract] [Full Text] [Related]
11. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
Lancet Child Adolesc Health; 2018 Dec 25; 2(12):855-862. PubMed ID: 30337183
[Abstract] [Full Text] [Related]
12. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
Zhonghua Er Ke Za Zhi; 2006 Dec 25; 44(12):891-5. PubMed ID: 17254453
[Abstract] [Full Text] [Related]
13. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
Paediatr Int Child Health; 2018 Aug 25; 38(3):209-212. PubMed ID: 29768976
[Abstract] [Full Text] [Related]
14. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM, Silverman ED, McCrindle BW, Yeung RS.
J Pediatr; 2002 Apr 25; 140(4):450-5. PubMed ID: 12006960
[Abstract] [Full Text] [Related]
15. Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease.
Jibiki T, Kato I, Shiohama T, Abe K, Anzai S, Takeda N, Yamaguchi KI, Kanazawa M, Kurosaki T.
Pediatr Int; 2011 Oct 25; 53(5):729-735. PubMed ID: 21342358
[Abstract] [Full Text] [Related]
16. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar 25; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
17. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
Front Immunol; 2021 Mar 25; 12():624802. PubMed ID: 33912155
[Abstract] [Full Text] [Related]
18. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
Lee KY, Han JW, Lee HS, Hong JH, Hahn SH, Lee JS, Whang KT.
Pediatr Infect Dis J; 2004 Jan 25; 23(1):52-5. PubMed ID: 14743047
[Abstract] [Full Text] [Related]
19. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.
Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, Zhou T, Wang Z, Martinek M, Pürerfellner H, Liu S, Krucoff MW.
JAMA Pediatr; 2016 Dec 01; 170(12):1156-1163. PubMed ID: 27749951
[Abstract] [Full Text] [Related]
20. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May 01; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
